Publications

Kiseleva AA, Korobeynikov VA, Nikonova AS, Zhang P, Makhov P, Deneka AY, Einarson MB, Serebriiskii IG, Liu H, Peterson JR, Golemis EA “Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs”, Clin Cancer Res. 2019 Jul 1;25(13):4179-4193. Epub 2019 Mar 13. PMID:30867219 PMCID:PMC6606352

Zhang, T., Yin, C., Boyd, D.F., Quarato, G., Ingram, J.P., Shubina, M., Ragan, K.B., Ishizuka, T., Crawford, J.C., Tummers, B., Rodriguez, D.A., Xue, J., Peri, S., Kaiser, W.J., Lopez, C.B., Xu, Y., Upton, J.W., Thomas, P.G., Green, D.R., Balachandran, S. “Influenza virus Z-RNAs induce ZBP1-mediated necroptosis”. Cell 180(6): 1115-1129, 2020.  PMID: 32200799 PMCID: PMC7153753

Gabitova-Cornell L, Surumbayeva A, Peri S, Franco-Barraza J, Restifo D, Weitz N, Ogier C, Goldman AR, Hartman TR, Francescone R, Tan Y, Nicolas E, Shah N, Handorf EA, Cai KQ, O'Reilly AM, Sloma I, Chiaverelli R, Moffitt RA, Khazak V, Fang CY, Golemis EA, Cukierman E, Astsaturov I. “Cholesterol Pathway Inhibition Induces TGF-beta Signaling to Promote Basal Differentiation in Pancreatic Cancer”. Cancer Cell 2020, 38:567-83 e11. PMID: 32976774 PMCID: PMC7572882

Sikder RK, Elithi M, Uzzo RN, Weader D, Metz AL, Behbahani A, McKenzie ER, El-Deiry WS, and Philip H. Abbosh. “Differential effects of clinically-relevant N- vs C-terminal truncating CDKN1A mutations on cisplatin sensitivity in bladder cancer”, Mol Cancer Res. 2021 Mar; 19(3): 403–413. PMCID: PMC7925368 NIHMSID: NIHMS1650312 PMID: 33272936 

Fan Q, Gong T, Zheng C, Ng JMY, Chen J, Myers C, Hensley HH, Curran T, Yang ZJ. “Statins repress hedgehog signaling in medulloblastoma with no bone toxicities”, Oncogene. 2021 Mar;40(12):2258-2272. PMID: 33649536 

Wu W, Wang W, Franzen CA, Guo H, Lee J, Li Y, Sukhanova M, Sheng D, Venkataraman G, Ming M, Lu P, Gao A, Xia C, Li J, Zhang LL, Jiang VC, Wang ML, Andrade J, Zhou X and Wang YL. “Inhibition of B-Cell Receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2”. PMID: 33570628. Blood Adv 5: 185–197, 2021 

Sertori R, Lin JX, Martinez E, Rana S, Sharo A, Kazemian M, Sunderam U, Andrake M, Shinton S, Truong B, Dunbrack RM, Liu C, Srinivasan R, Brenner SE, Seroogy CM, Puck JM, Leonard WJ, Wiest DL. “Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency”. Front Immunol. 2022; 13: 928252. PMCID: PMC9372720 PMID: 35967429 

Sementino E, Kadariya Y, Cheung M, Menges CW, Tan Y, Kukuyan AM, Shrestha U, Karchugina S, Cai KQ, Peri S, Duncan JS, Chernoff J, Testa JR. “Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling”. Mol Cancer Res. 2022 May 4; 20(5): 699–711. PMCID: PMC9081258, PMID: 35082167 

Zhang T, Yin C, Fedorov A, Qiao L, Bao H, Beknazarov N, Wang S, Gautam A, Williams RM, Crawford JC, Peri S, Studitsky V, Beg AA, Thomas PG, Walkley C, Xu Y, Poptsova M, Herbert A, Balachandran S. “ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis”. Nature. 606(7914):594-602, 2022. PMID: 35614224 PMCID: PMC9373927

Tricarico R., Madzo J., Scher G., Cohen M., Jelinek J., Maegawa S., Nagarathinam R., Scher C., Chang W.C., Nicolas E., Slifker M., Zhou Y., Devarajan K., Cai K.Q., Kwok T., Nakajima P., Xu J., Mancuso P., Doneddu V., Bagella L., Williams R., Balachandran S., Maskalenko N., Campbell K., Ma X., Cañadas I., Viana J., Moreno V., Valle L., Grivennikov S., Peshkova I., Kurilenko N., Mazitova A., Koltsova E., Lee H., Walsh M., Duttweiler R., Whetstine J.R., Yen T.J., Issa J.P., Bellacosa A., “TET1 and TDG suppress inflammatory response in intestinal tumorigenesis: Implications for colorectal tumors with the CpG island methylator phenotype.” Gastroenterology, 2023. PMID36764492.